相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Revised Neuroblastoma Risk Classification System: A Report From the Children's Oncology Group
Meredith S. Irwin et al.
JOURNAL OF CLINICAL ONCOLOGY (2021)
Maintaining Outstanding Outcomes Using Response- and Biology-Based Therapy for Intermediate-Risk Neuroblastoma: A Report From the Children’s Oncology Group Study ANBL0531
Clare J. Twist et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Unfavorable Outcome of Neuroblastoma in Patients With 2p Gain
Katarzyna Szewczyk et al.
FRONTIERS IN ONCOLOGY (2019)
Influence of segmental chromosome abnormalities on survival in children over the age of 12 months with unresectable localised peripheral neuroblastic tumours without MYCN amplification
R. Defferrari et al.
BRITISH JOURNAL OF CANCER (2015)
Revised Risk Estimation and Treatment Stratification of Low- and Intermediate-Risk Neuroblastoma Patients by Integrating Clinical and Molecular Prognostic Markers
Andre Oberthuer et al.
CLINICAL CANCER RESEARCH (2015)
Treatment of children over the age of one year with unresectable localised neuroblastoma without MYCN amplification: Results of the SIOPEN study
J. A. Kohler et al.
EUROPEAN JOURNAL OF CANCER (2013)
Segmental chromosomal alterations lead to a higher risk of relapse in infants with MYCN-non-amplified localised unresectable/disseminated neuroblastoma (a SIOPEN collaborative study)
G. Schleiermacher et al.
BRITISH JOURNAL OF CANCER (2011)
Management and outcome of stage 3 neuroblastoma
Shakeel Modak et al.
EUROPEAN JOURNAL OF CANCER (2009)
Poor Survival for Infants With MYCN-Amplified Metastatic Neuroblastoma Despite Intensified Treatment: The International Society of Paediatric Oncology European Neuroblastoma Experience
Adela Canete et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Excellent Outcome With Reduced Treatment for Infants With Disseminated Neuroblastoma Without MYCN Gene Amplification
Bruno De Bernardi et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
The International Neuroblastoma Risk Group (INRG) Staging System: An INRG Task Force Report
Tom Monclair et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
The International Neuroblastoma Risk Group (INRG) Classification System: An INRG Task Force Report
Susan L. Cohn et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Long-term Outcomes in Survivors of Neuroblastoma: A Report From the Childhood Cancer Survivor Study
Caroline Laverdiere et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2009)
Treatment of localised resectable neuroblastoma. Results of the LNESG1 study by the SIOP Europe Neuroblastoma Group
B. De Bernardi et al.
BRITISH JOURNAL OF CANCER (2008)
Identification of ALK as a major familial neuroblastoma predisposition gene
Yael P. Mosse et al.
NATURE (2008)
Somatic and germline activating mutations of the ALK kinase receptor in neuroblastoma
Isabelle Janoueix-Lerosey et al.
NATURE (2008)
Review of image defined risk factors in localized neuroblastoma patients: Results of the GPOH NB97 trial
Thorsten Simon et al.
PEDIATRIC BLOOD & CANCER (2008)
Chromosomal CGH identifies patients with a higher risk of relapse in neuroblastoma without MYCN amplification
G. Schleiermacher et al.
BRITISH JOURNAL OF CANCER (2007)
Surgical risk factors in primary surgery for localized neuroblastoma:: The LNESG1 study of the European International Society of Pediatric Oncology Neuroblastoma Group
G Cecchetto et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Long-term renal and hearing toxicity of carboplatin in infants treated for localized and unresectable neuroblastoma: Results of the SFOPNBL90 study
C Bergeron et al.
PEDIATRIC BLOOD & CANCER (2005)
分享论文
